{
    "nctId": "NCT06321653",
    "briefTitle": "Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes",
    "officialTitle": "AXILL-ART: Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes Without Axillary Dissection in Breast Cancer Conservative Surgery: Observational Study",
    "overallStatus": "RECRUITING",
    "conditions": "Arm Lymphedema, Breast Cancer, Radiotherapy Side Effect",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Percentage of patients with arm lymphedema",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Histological proven invasive breast cancer\n2. Breast conserving surgery with no axillary dissection\n3. Tumor dimension no more then 5 cm and no more than 2 positive sentinel node\n\n5) Negative surgical margin (no tumor cell on ink) 6) Performance Status (PS) \\<2 7) Age \\>18 8) Written informed consent\n\nExclusion Criteria:\n\n1. Previous thoracic RT\n2. Mixed connective disorders\n3. Distant metastases\n4. Severe lung or cardiac diseases\n5. Neoadjuvant systemic therapies\n6. Axillary dissection\n7. No surgical axillary investigation\n8. Mastectomy\n9. Axillary micrometastasis or isolated tumor cell",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}